Rankings
▼
Calendar
IVVD Q1 2023 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$257M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$39M
Net Income
-$35M
EPS (Diluted)
$-0.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$42M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$351M
Total Liabilities
$24M
Stockholders' Equity
$327M
Cash & Equivalents
$126M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$39M
-$101M
+61.2%
Net Income
-$35M
-$101M
+64.9%
← FY 2023
All Quarters
Q2 2023 →